VanEck Vectors Profile

127.48
USD 1.94  1.5%
36%
40%

VanEck Vectors Summary

VanEck Vectors Biotech ETF [BBH] is traded in USA and was established 2011-12-20. The fund is classified under Health category within VanEck family. VanEck Vectors Biotech ETF currently have 475.89 M in assets under management (AUM). , while the total return for the last 3 years was 6.37%.
Check VanEck Vectors Probability Of Bankruptcy

Geographic Allocation (%)

VanEck Vectors Biotech Currency Exposure (%)

 % of ETF 
      Currency 

Top Etf Constituents

VanEck Vectors Target Price Odds Analysis

Odds Below 127.48HorizonTargetOdds Above 127.48
16.93%30 days 127.48 82.82%
Based on normal probability distribution, the odds of VanEck Vectors to move above current price in 30 days from now is about 82.82% (This VanEck Vectors Biotech ETF probability density function shows the probability of VanEck Vectors Etf to fall within a particular range of prices over 30 days) .

VanEck Vectors Biotech Risk Profiles

VanEck Vectors Biotech Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of seventeen. VanEck Vectors Biotech Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe VanEck Vectors price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

VanEck Vectors Key Fundamentals

VanEck Vectors Against Markets

VanEck Vectors Current Ratings

VanEck Vectors Biotech ETF 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
8 
Equity ratings for VanEck Vectors Biotech ETF are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. VanEck Vectors is traded on NASDAQ General Markets in USA. more
NameVanEck Vectors Biotech ETF
ChairmanPhilip HornigView All
Macroaxis Advice
InstrumentUSA Etf View All
RegionGlobal
Investment IssuerVan Eck
ExchangeNASDAQ General Markets
Etf FamilyVanEck
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Phone800 826 2333
CurrencyUSD - US Dollar
IssuerVan Eck
DescriptionVanEck Vectors Biotech ETF
Inception Date2011-12-20
BenchmarkMV US Listed Biotech 25 NR USD
Entity TypeRegulated Investment Company
Asset Under Management471.95 Million
Average Trading Valume14,168
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionGlobal
AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianThe Bank of New York Mellon Corporation
DistributorVan Eck Securities Corporation
Portfolio ManagerHao-Hung (Peter) Liao, Guo Hua (Jason) Jin
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year EndSeptember 30
ExchangeThe NASDAQ Stock Market LLC
Number of Constituents26.0
Market MakerVirtu Financial
Total Expense0.39
Management Fee0.35
Nav Price136.11
Last Bear Mkt0.00%
Two Hundred Day Average124.05
Ytd9.18%
Average Daily Volume In Three Month15.16k
Fifty Two Week Low111.36
Last Bull Mkt0.00%
Average Daily Volume Last 10 Day17.76k
Fifty Two Week High136.84
One Month0.64%
Fifty Day Average132.54
Check also Trending Equities. Please also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Search macroaxis.com